Xenon Pharmaceuticals Inc. · NASDAQ:XENE

Gannon Steven exercised options for 2,645 Xenon Pharmaceuticals Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Gannon Steven (Director) exercised options for 2,645 Xenon Pharmaceuticals Inc. shares, leaving 11,870 shares. Filed Jun 3, 2026 (Form 4).

Options exercised
2,645 shares
Holding after
11,870 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 1, 2026Common SharesOption exercise2,64513,286Direct
Jun 1, 2026Common SharesShares withheld for tax1,416US$53.4111,870Direct

Source

View original at SEC

Related